Related Experiment Video

Updated: May 15, 2026

Measuring Composition of CD95 Death-Inducing Signaling Complex and Processing of Procaspase-8 in this Complex
07:17

Measuring Composition of CD95 Death-Inducing Signaling Complex and Processing of Procaspase-8 in this Complex

Published on: August 2, 2021

B cell survival, surface BCR and BAFFR expression, CD74 metabolism, and CD8- dendritic cells require the

Hannes Bergmann1, Mehmet Yabas, Alanna Short

  • 1Ramaciotti Immunization Genomics Laboratory, John Curtin School of Medical Research, The Australian National University, Canberra, Australian Capital Territory 2600, Australia.

The Journal of Experimental Medicine
|December 26, 2012
PubMed

Insights

Signal peptide peptidase-like 2A (SPPL2A) deficiency in mice impairs B cell development and immune responses by blocking CD74 processing. This highlights SPPL2A as a potential therapeutic target for B cell diseases.

Area of Science:

  • Immunology
  • Molecular Biology
  • Protease Function

Background:

  • Druggable proteins regulating B lymphocyte survival are key for treating autoimmunity and lymphoid malignancies.
  • Signal peptide peptidase-like 2A (SPPL2A) is an intramembrane protease.
  • BAFF (B cell-activating factor) is a cytokine crucial for B cell survival.

Purpose of the Study:

  • To investigate the role of SPPL2A in B cell development and immune responses.
  • To understand the molecular mechanisms underlying SPPL2A-mediated effects on B cells and dendritic cells.
  • To identify potential therapeutic targets for B cell-related diseases.

Main Methods:

  • Inactivating mutation in SPPL2A in mice.
  • Flow cytometry to analyze B cell subsets and surface receptors.
  • Analysis of CD74 MHC II invariant chain processing and Cathepsin S activity.
  • Gene expression analysis (BCL2 and BAFF).

Main Results:

  • SPPL2A deficiency led to profound humoral immunodeficiency and lack of mature B cells.
  • B cell accumulation in Sppl2a-deficient mice was rescued by BCL2, not BAFF.
  • SPPL2A deficiency blocked CD74 proteolytic processing, increasing Cathepsin S p8 product and impairing CD74 endosomal processing.
  • CD8-negative dendritic cells were also significantly decreased.

Conclusions:

  • SPPL2A plays a critical role in the final step of the CD74-MHC II pathway.
  • SPPL2A deficiency disrupts B cell maturation and immune function.
  • SPPL2A represents a novel therapeutic target for protease inhibitor treatment of B cell diseases.

More Related Videos

Preparation of Bead-supported Lipid Bilayers to Study the Particulate Output of T Cell Immune Synapses11:06

Preparation of Bead-supported Lipid Bilayers to Study the Particulate Output of T Cell Immune Synapses

Published on: April 1, 2022

Studying Organelle Dynamics in B Cells During Immune Synapse Formation15:39

Studying Organelle Dynamics in B Cells During Immune Synapse Formation

Published on: June 1, 2019

Related Concept Videos

B Cell Activation and Differentiation01:24

B Cell Activation and Differentiation

The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Antigen Processing Pathways01:31

Antigen Processing Pathways

MHC molecules are key players in the immune response, enabling T cells to recognize and respond to specific antigens. They are present on the surface of all nucleated cells in the body and are instrumental in presenting antigens to T cells and activating them. T cells recognize the MHC-antigen complex and initiate an immune response. MHC class I and MHC class II are two main types of MHC molecules, each associated with a distinct antigen processing pathway.
MHC Class I: Presenting Endogenous...